# NIH Reporter #3U19CA264504-05S1

Harvard/Stanford GTN Program:  Novel targeted therapeutics for glioblastoma

**Recipient:** Brigham and Women's Hospital

**Award Amount:** $927,126.00
**Ceiling:** $927,126.00

**Awarded:** September 17, 2026

**Identifier:** 3U19CA264504-05S1

Research grant awarded to Harvard and Stanford for developing novel targeted therapeutics for glioblastoma, focusing on pediatric and young adult populations.

### Description

This is a research grant opportunity for projects related to glioma therapeutics, with a focus on pediatric and young adult populations. The project involves multiple research projects and clinical trials, with collaboration between Harvard and Stanford.

[View original record](https://reporter.nih.gov/search/IgE1H2ioLUOz0qmA4MDg0Q/project-details/11608562)